Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

What’s Next for Left Main PCI?

CME

What’s Next for Left Main PCI?

Updates on Onyx ONE

CME

Updates on Onyx ONE

TAVR: The Heart Team Approach

CME

TAVR: The Heart Team Approach

Role of Interventional Cardiologists in Secondary Prevention of Acute Coronary Syndromes: Redefining Clinical Practice

CME

Role of Interventional Cardiologists in Secondary Prevention of Acute Coronary Syndromes: Redefining Clinical Practice

PERSPECTIVEs on CTO: New Evidence and Novel Approaches

CME

PERSPECTIVEs on CTO: New Evidence and Novel Approaches

Optimizing the Duration of DAPT following PCI

CME

Optimizing the Duration of DAPT following PCI

Optimizing Outcomes During and After PCI: From Intravenous to Oral Platelet Inhibition

CME

Optimizing Outcomes During and After PCI: From Intravenous to Oral Platelet Inhibition

Latest Data on Left Main Stenting and its Implications

CME

Latest Data on Left Main Stenting and its Implications

Everyday Antiplatelet Decisions: Making the Right Choices

CME

Everyday Antiplatelet Decisions: Making the Right Choices

Drug Eluting Stents: How Low Can Events Go? Integrating New Randomized Trial Data Into Clinical Practice

CME

Drug Eluting Stents: How Low Can Events Go? Integrating New Randomized Trial Data Into Clinical Practice

Contemporary ACS Management: Why GPIs are Finding Their Way Back Into the Cath Lab

CME

Contemporary ACS Management: Why GPIs are Finding Their Way Back Into the Cath Lab

Changing Course with Anticoagulation in Secondary Prevention of CAD

CME

Changing Course with Anticoagulation in Secondary Prevention of CAD

Balancing Ischemic and Bleeding Risk with Antiplatelet Therapy: Personalizing Treatment to Optimize Outcomes

CME

Balancing Ischemic and Bleeding Risk with Antiplatelet Therapy: Personalizing Treatment to Optimize Outcomes

PLX Pharma - Aspirin for the Interventionalist: More Than Meets the Eye

CME

Aspirin for the Interventionalist: More Than Meets the Eye

A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibitors after PCI

CME

A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibitors after PCI

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.